POSITRON CORPORATION

POSC ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $461.5K $587.5K $1.5M $1.6M $2.8M $6.7M $4.6M
Cost of Revenue $2.6M $929.5K $1.4M $1.2M $2.0M $6.4M $4.6M
Gross Profit $-2.1M $-342.0K $104.0K $424.0K $829.0K $277.0K $59.0K
Gross Margin -458.2% -58.2% 7.1% 26.0% 29.6% 4.2% 1.3%
Operating Expenses
Research & Development $471.0K $564.0K $940.0K $1.3M $1.3M
SG&A Expense $8.4M $1.9M $2.2M $2.8M $4.3M $2.3M $12.1M
Operating Income $-10.5M $-2.2M $-2.7M $-3.3M $-4.7M $-4.4M $-14.4M
Operating Margin -2,275.1% -375.3% -187.1% -204.8% -168.6% -65.9% -312.4%
Interest Expense $125.3K $142.4K $1.8M $2.1M $1.8M $1.2M $43.0K
Pretax Income $-2.6M $-7.1M $-8.0M $-6.1M $-10.9M
Income Tax Expense $0 $0 $0 $0
Net Income $-10.6M $-2.4M $-2.6M $-7.1M $-8.0M $-6.1M $-10.9M
Net Margin -2,297.8% -405.0% -176.3% -435.8% -284.0% -91.9% -236.3%
EPS (Basic) $-0.34 $-0.09 $0.00 $0.00 $-0.01 $-0.01 $-0.02
EPS (Diluted) $-0.34 $-0.09 $0.00 $0.00 $-0.01 $-0.01 $-0.02
Shares Outstanding (Basic) 30.9M 26.0M 5.55B 1.45B 1.45B 788.3M 782.7M
Shares Outstanding (Diluted) 30.9M 26.0M 5.55B 1.45B 1.45B 788.3M 782.7M
Dividends Per Share